A protooncogene c-MYB was recently showed to contribute to cisplatin resistance in ovarian cancer9 and these reported results were the first ever detailing the c-MYBs contribution to proliferation, invasion and development of cisplatin resistance in ovarian cancer cells. Here, MYB is linked to ovarian carcinoma.